| Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients MG Friedrich, DJ Weisenberger, JC Cheng, S Chandrasoma, ... Clinical Cancer Research 10 (22), 7457-7465, 2004 | 263 | 2004 |
| Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma MG Friedrich, S Chandrasoma, KD Siegmund, DJ Weisenberger, ... European Journal of Cancer 41 (17), 2769-2778, 2005 | 158 | 2005 |
| High-accuracy prostate cancer pathology using deep learning Y Tolkach, T Dohmgörgen, M Toma, G Kristiansen Nature Machine Intelligence 2 (7), 411-418, 2020 | 140 | 2020 |
| Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma B Langhans, HD Nischalke, B Krämer, L Dold, P Lutz, R Mohr, A Vogt, ... Cancer Immunology, Immunotherapy 68, 2055-2066, 2019 | 131 | 2019 |
| Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer MI Toma, MG Friedrich, SH Hautmann, KT Jäkel, A Erbersdobler, ... World journal of urology 22, 145-149, 2004 | 128 | 2004 |
| Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease‐free interval and the number of metastases per patient D Wuttig, B Baier, S Fuessel, M Meinhardt, A Herr, C Hoefling, M Toma, ... International journal of cancer 125 (2), 474-482, 2009 | 124 | 2009 |
| Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison S Hautmann, M Toma, MFL Gomez, MG Friedrich, T Jaekel, U Michl, ... European urology 46 (4), 466-471, 2004 | 118 | 2004 |
| Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer MG Friedrich, MI Toma, A Hellstern, K Pantel, DJ Weisenberger, J Noldus, ... BJU international 92 (9), 911-914, 2003 | 113 | 2003 |
| Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array MI Toma, M Grosser, A Herr, DE Aust, A Meye, C Hoefling, S Fuessel, ... Neoplasia 10 (7), 634-642, 2008 | 101 | 2008 |
| Comprehensive evaluation of prostate specific membrane antigen expression in the vasculature of renal tumors: implications for imaging studies and prognostic role S Spatz, Y Tolkach, K Jung, C Stephan, J Busch, B Ralla, A Rabien, ... The Journal of urology 199 (2), 370-377, 2018 | 99 | 2018 |
| CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastases D Wuttig, S Zastrow, S Füssel, MI Toma, M Meinhardt, K Kalman, K Junker, ... International journal of cancer 131 (5), E693-E704, 2012 | 95 | 2012 |
| GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy A Mukha, U Kahya, A Linge, O Chen, S Löck, V Lukiyanchuk, S Richter, ... Theranostics 11 (16), 7844, 2021 | 94 | 2021 |
| Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography‐fusion biopsy A Borkowetz, I Platzek, M Toma, T Renner, R Herout, M Baunacke, ... BJU international 118 (2), 213-220, 2016 | 92 | 2016 |
| Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer A Borkowetz, I Platzek, M Toma, M Laniado, G Baretton, M Froehner, ... BJU international 116 (6), 873-879, 2015 | 89 | 2015 |
| LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma N Klümper, DJ Ralser, EG Bawden, J Landsberg, R Zarbl, G Kristiansen, ... Journal for immunotherapy of cancer 8 (1), 2020 | 84 | 2020 |
| An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells C Peitzsch, M Cojoc, L Hein, I Kurth, K Mäbert, F Trautmann, B Klink, ... Cancer research 76 (9), 2637-2651, 2016 | 81 | 2016 |
| Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer NT Gaisa, T Braunschweig, N Reimer, J Bornemann, E Eltze, S Siegert, ... Virchows Archiv 458, 301-312, 2011 | 77 | 2011 |
| Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis MG Friedrich, MI Toma, S Petri, JC Cheng, P Hammerer, A Erbersdobler, ... European urology 45 (6), 737-743, 2004 | 75 | 2004 |
| Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with enfortumab vedotin resistance N Klümper, DJ Ralser, J Ellinger, F Roghmann, J Albrecht, E Below, ... Clinical Cancer Research 29 (8), 1496-1505, 2023 | 72 | 2023 |
| The N6‐methyladenosine (m6A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity‐associated protein (FTO) are prognostic biomarkers … A Strick, F von Hagen, L Gundert, N Klümper, Y Tolkach, D Schmidt, ... BJU international 125 (4), 617-624, 2020 | 68 | 2020 |
